The use of resveratrol in a 4T1 metastatic breast cancer murine model achieved shrinkage of lung metastasis, a result that was attributed to Breg inhibition, and consequently, TGF-β downregulation, through inactivation of Stat3 [110]. The gene discussed is TGFB1; the disease is breast cancer.